A 6-month-old infant with a history of poor feeding and developmental delay is found to have elevated serum phenylalanine (850 µmol/L) and normal tyrosine levels on plasma amino acid analysis. Phenylalanine hydroxylase activity is normal on liver biopsy. Which investigation would best identify the underlying defect?

Explanation

## Diagnosis of Tetrahydrofolate (BH₄)-Deficient Hyperphenylalaninemia ### Clinical Context This case presents a critical diagnostic dilemma: elevated phenylalanine with **normal phenylalanine hydroxylase activity** on liver biopsy. This rules out classic PKU and points to a **cofactor deficiency** — specifically **tetrahydrofolate (BH₄) deficiency**. ### Why Serum BH₄ and Urine Pterins (HPLC) is Correct **Key Point:** BH₄-deficient hyperphenylalaninemia is a treatable variant of elevated phenylalanine caused by defects in BH₄ synthesis or regeneration, NOT phenylalanine hydroxylase itself. The investigation of choice is: - **Serum BH₄ level** — directly measures the cofactor - **Urine pterins by HPLC** — detects abnormal pterins (neopterin, biopterin) that indicate impaired BH₄ metabolism These tests definitively identify the metabolic block and guide specific therapy (BH₄ supplementation, folinic acid, carbidopa). ### Biochemistry of BH₄ Deficiency **High-Yield:** BH₄ is an essential cofactor for three monoamine oxidase enzymes: 1. **Phenylalanine hydroxylase** (Phe → Tyr) 2. **Tyrosine hydroxylase** (Tyr → DOPA → dopamine) 3. **Tryptophan hydroxylase** (Trp → 5-HTP → serotonin) When BH₄ is deficient: - Phenylalanine accumulates (Phe hydroxylase cannot function) - Tyrosine is **normal or elevated** (because it is not consumed by tyrosine hydroxylase) - Dopamine and serotonin are deficient → neurological symptoms (seizures, developmental delay, hypotonia) **Mnemonic:** **BH₄ = Big Helper for 4 enzymes** — Phenylalanine hydroxylase, Tyrosine hydroxylase, Tryptophan hydroxylase, and Nitric oxide synthase. ### Pathophysiology of BH₄ Deficiency Defects in BH₄ synthesis or regeneration: - **GTP cyclohydrolase I deficiency** (most common) - **6-Pyruvoyl-tetrahydrofolate synthase deficiency** - **Dihydrofolate reductase deficiency** - **Sepiapterin reductase deficiency** Each causes accumulation of specific pterins in urine, identifiable by HPLC. ### Why Normal Phenylalanine Hydroxylase Activity Rules Out Classic PKU In classic PKU, the enzyme itself is defective or absent. Here, the enzyme is **functionally normal** but cannot work because its cofactor is missing — a crucial distinction that changes management entirely. ### Comparison of Investigations | Investigation | Detects | Utility in This Case | |---|---|---| | **Serum BH₄ + urine pterins (HPLC)** | Cofactor deficiency; specific pterins identify the enzyme defect | **GOLD STANDARD** — directly identifies BH₄ deficiency and subtype | | **Urine organic acids** | Phenylpyruvate, phenylacetate | Non-specific; present in any hyperphenylalaninemia; does not identify cofactor defect | | **Liver PAH gene sequencing** | Mutations in PAH gene | **Normal in this case** — enzyme activity is normal, so gene is intact | | **Serum catecholamines** | Dopamine, norepinephrine levels | Low in BH₄ deficiency but not diagnostic; requires HPLC and is non-specific | **Clinical Pearl:** BH₄-deficient hyperphenylalaninemia is **treatable** with BH₄ supplementation (sapropterin), folinic acid, and dopamine/serotonin precursors. Missing this diagnosis and treating only with phenylalanine restriction will NOT prevent neurological deterioration because dopamine and serotonin deficiency will persist. ### Management Implication Once BH₄ deficiency is confirmed, therapy includes: 1. **Sapropterin (synthetic BH₄)** — 5–20 mg/kg/day 2. **Folinic acid** — to replenish folate 3. **Levodopa + carbidopa** — to bypass dopamine deficiency 4. **5-hydroxytryptophan** — to bypass serotonin deficiency 5. **Dietary Phe restriction** — secondary measure